Anti‐tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non‐infectious uveitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐tumour Necrosis Factor Biological Therapies for the Treatment of Uveitic Macular Oedema (UMO) for Non‐infectious Uveitis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438461/1/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients_New. Accessed 18 April 2024.
Anti‐tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non‐infectious uveitis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438461/1/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients_New. Accessed April 18, 2024.
Anti‐tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non‐infectious uveitis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438461/1/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients_New
Anti‐tumour Necrosis Factor Biological Therapies for the Treatment of Uveitic Macular Oedema (UMO) for Non‐infectious Uveitis [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438461/1/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non‐infectious uveitis
ID - 438461
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438461/1/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients_New
DB - Evidence Central
DP - Unbound Medicine
ER -